Cargando…
Effectiveness of benralizumab for allergic and eosinophilic predominant asthma following negative initial results with omalizumab
A 64‐year‐old woman, who had presented with a 30‐year history of refractory asthma, and been treated with anti‐allergic drug therapy, inhaled corticosteroids, a long‐acting beta‐agonist, and a long‐acting muscarinic antagonist. She had been characterized as an allergic, eosinophilic asthmatic. Altho...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249091/ https://www.ncbi.nlm.nih.gov/pubmed/30479771 http://dx.doi.org/10.1002/rcr2.388 |